HB Wealth Management LLC’s holdings in AstraZeneca were worth $1,932,000 as of its most recent filing with the Securities and Exchange Commission. SCS Capital Management LLC bought a new position in AstraZeneca during the first quarter worth $3,066,000. AstraZeneca PLC has a 1-year low of $61.24 and a 1-year high of $84.61. Analysts predict that AstraZeneca PLC will post 4.51 EPS for the current fiscal year. Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AstraZeneca PLC (NASDAQ:AZN – Free Report).